4//SEC Filing
QUESTCOR PHARMACEUTICALS INC 4
Accession 0001181431-13-054085
CIK 0000891288operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 6:57 PM ET
Size
10.3 KB
Accession
0001181431-13-054085
Insider Transaction Report
Form 4
THOMPSON VIRGIL D
Director
Transactions
- Sale
Common Stock
2013-10-14$60.86/sh−900$54,770→ 29,867 total - Exercise/Conversion
Common Stock
2013-10-14$4.50/sh+2,500$11,250→ 32,367 total - Exercise/Conversion
Stock Option (right to buy)
2013-10-14−2,500→ 0 totalExercise: $4.50Exp: 2018-02-27→ Common Stock (2,500 underlying) - Sale
Common Stock
2013-10-14$60.30/sh−1,600$96,484→ 30,767 total
Footnotes (3)
- [F1]Non-qualified stock options were granted under the Company's 2006 Equity Incentive Award Plan.
- [F2]The option was granted on 02/29/2008 for the right to buy 7,500 shares of common stock of the Issuer. The options vested 100% on the date of grant.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.71-$60.71 and $60.72-$60.99, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Documents
Issuer
QUESTCOR PHARMACEUTICALS INC
CIK 0000891288
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000891288
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 6:57 PM ET
- Size
- 10.3 KB